Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |